Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like Bleeding Money, s NantHealth Restructures and Lays Off 300 August 10, 2017 How GlaxoSmithKline Lost Nearly $10B in October November 9, 2017 Invacare Proposes $100 Million Raise June 8, 2017
